The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

June 12, 2014

Primary Completion Date

March 8, 2017

Study Completion Date

July 24, 2017

Conditions
Obsessive-Compulsive Disorder
Interventions
BEHAVIORAL

cognitive behavioral group therapy

"Establish closed every collection of six or so patients structured group. Each group patients were treated for 12 times, once a week, 120 minutes at a time.~Treatment for 1 to 3 times to obsessive-compulsive disorder and cognitive behavioral therapy as the theme of psychological education; 4 to 6, 8 to 10 times exposed step by step and reaction treatment and prevention of training;7 and 11 times invite patients family members or other caregivers, make education about obsessive-compulsive disorder cognitive behavioural therapy, to promote patients exposed response prevention homework completion and social support; The 12th time treatment is self assessment and treatment guidelines for a long time."

DRUG

sertraline, fluvoxamine

Select specified drugs (sertraline, fluvoxamine)

OTHER

cognitive behavioral group therapy and drug therapy

Select specified drugs (sertraline, fluvoxamine) and start group cognitive behavior therapy for 12 weeks at the same time

Trial Locations (1)

200030

Clinical psychiatrist, Shanghai

All Listed Sponsors
lead

Shanghai Mental Health Center

OTHER

NCT02739061 - The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder | Biotech Hunter | Biotech Hunter